George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes & Business and Strategy Update

4 Jan 2024 07:00

RNS Number : 5879Y
Iconic Labs PLC
04 January 2024
 

4 January 2024

 

Iconic Labs PLC

 

("Iconic" or the "Company")

 

Board Changes

 

Business and Strategy Update

 

Iconic Labs PLC (LSE: ICON), is pleased to announce the appointment of Victor Humberdot and Bela Lendvai-Lintner as Non-executive Directors to the Board of Iconic, as well as an update on the business and strategy of the Company.

 

Board Changes

 

Victor Humberdot and Bela Lendvai-Lintner have been appointed as Non-executive Directors with immediate effect and will replace Marija Hrebac, David Stybr and Emmanuel Blouin who have stepped down from the Board.

 

Victor Humberdot (aged 34) is an experienced investment banker. Having started his career at BBVA and Kepler Cheuvreux, he then joined the investment fund of Société Générale, Private Banking in Luxembourg before, most recently, being responsible for the external growth of an investment holding company in the construction sector before being M&A Manager at Exponens Corporate Finance and more recently a Vice President at the corporate finance boutique, DDA & Company in Paris. He is currently Founder and CEO of HUVI Capital, his own investment holding company. Victor holds a master's degree in international finance from Neoma Business School and a master's in physics and mechanical engineering from Le Havre Normandy University.

 

Bela Lendvai-Lintner (aged 48) has more than 20 years of experience in private equity within a wide range of industry sectors. He started his career at KPMG in corporate finance focused on M&A transactions. Bela has also held multiple roles at ARX Equity Partners, an independent Central Europe-focused mid-market buyout firm and is currently a Partner and Investment Committee Member. He holds a Bachelor of Science in Business Administration/Finance from Ohio State University.

 

Business and Strategy Update

 

In conjunction with these Board changes, Iconic is also focusing on its strategy. Earlier in 2023, Iconic intended to establish a strategic advisory services business, engaging in fee-based service contracts with technology companies. The objective was to provide valuable guidance on growth plans, product development, marketing and capital raising.

 

However, following the successful Company restructuring, and its exit from administration, Iconic is now channelling all its efforts towards identifying a suitable acquisition target, most likely in the form of a reverse takeover ("RTO") target. Whilst the Company continues to narrow down the pool of viable acquisition candidates, in parallel, Iconic will continue to develop, with its strategic partners, its sole asset, Gay Star News, an online media platform dedicated to the LGBTQ+ community.

 

Iconic is confident that this strategic shift will pave the way for long-term growth and create substantial value for its shareholders.

 

Brad Taylor, Chief Executive Officer of Iconic Labs PLC, commented:

 

"I would like to extend my gratitude to Marija, Emmanuel and David for their unwavering support and guidance in navigating us through the complex restructuring of the Company with an exceptionally high level of professionalism and skill.

 

"As the Company pivots to focus all efforts on acquiring a suitable company through an RTO, I welcome Victor and Bela to the Board and look forward to working closely with them, who between them bring a blend of finance and industry experience to the Board which will prove invaluable in achieving our strategic objective of fostering long-term growth and value for all our shareholders."

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

Additional Information

 

Bela Lendvai-Lintner is currently or has been Director or Partner of the following companies and/or firms in the last five years:

 

Current Directorships

 

Accounting Partners Hungary Kft

XMobile International Kft

Pannon Provider Zrt

Beer=Win Holding Kft

Orenthal Kft

 

Previous Directorships

 

Gomba Invest Kft

 

Victor Humberdot is currently or has been Director or Partner of the following companies or firms in the last five years:

 

Current Directorships

 

HUVI Capital

IPAHUMA

 

Previous Directorships

 

Quickcool AB

 

For any further information or enquiries please contact:

 

Iconic Labs

Brad Taylor, Chief Executive Officer

Tel: +44 (0) 7462 156238

ir@iconiclabs.co.uk

Novum Securities Limited

David Coffman / Daniel Harris

 Tel: +44 (0) 20 7399 9400

 

Yellow Jersey PR

Sarah Hollins

Annabelle Wills

Bessie Elliot

 

 Tel: +44 (0) 20 3004 9512

 iconic@yellowjerseypr.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAFFDEDELEAA
Date   Source Headline
28th Mar 20247:00 amRNSInterim Results
11th Mar 202412:00 pmRNSHeads of Terms Signed
29th Feb 20247:00 amRNSTotal Voting Rights
29th Feb 20247:00 amRNSSuspension of Trading
13th Feb 20242:08 pmRNSResult of AGM
7th Feb 20249:10 amRNSConversion of Notes and Allotment of Shares
19th Jan 20243:49 pmRNSNotice of AGM
4th Jan 20247:00 amRNSBoard Changes & Business and Strategy Update
29th Dec 20237:00 amRNSTotal Voting Rights
7th Dec 20238:53 amRNSConversion of Securities
4th Dec 20237:53 amRNSConversion of Securities
30th Nov 20237:00 amRNSTotal Voting Rights
17th Nov 202311:32 amRNSConversion of Securities
13th Nov 20238:40 amRNSConversion of Securities
2nd Nov 202310:35 amRNSConversion of Securities
31st Oct 20239:29 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSFull Year Results for the Year ended 30 June 2023
24th Oct 20235:31 pmRNSChange of Auditor
17th Oct 20237:51 amRNSConversion of Securities
13th Oct 202311:32 amRNSAnnouncement of the Completion of CVA
13th Oct 202311:30 amRNSConversion of Securities
29th Sep 20238:01 amRNSTotal Voting Rights
22nd Sep 20239:40 amRNSConversion of Securities
18th Sep 20236:27 pmRNSConversion of Notes – Replacement
18th Sep 20237:37 amRNSConversion of Securities
12th Sep 20238:45 amRNSStatement re CVA
4th Sep 202312:02 pmRNSConversion of Securities
31st Aug 20237:21 amRNSTotal Voting Rights
25th Aug 20234:49 pmRNSResult of AGM
18th Aug 20237:51 amRNSConversion of Securities
14th Aug 20237:59 amRNSIssue of Debt
8th Aug 20232:58 pmRNSPublication of a Prospectus
4th Aug 20234:19 pmRNSNotice of AGM
30th Jun 20239:12 amRNSTotal Voting Rights
2nd Jun 20231:20 pmRNSIssue of Equity
28th Apr 202310:35 amRNSTotal Voting Rights
12th Apr 20238:13 amRNSConversion of Securities
31st Mar 20233:11 pmRNSTotal Voting Rights
31st Mar 20231:59 pmRNSHalf-year Report
29th Mar 20232:05 pmRNSSecond Price Monitoring Extn
29th Mar 20232:00 pmRNSPrice Monitoring Extension
28th Mar 20237:42 amRNSConversion of Securities
27th Mar 202311:05 amRNSSecond Price Monitoring Extn
27th Mar 202311:00 amRNSPrice Monitoring Extension
22nd Mar 202311:48 amRNSSubscription of Convertible Notes
21st Mar 202311:05 amRNSSecond Price Monitoring Extn
21st Mar 202311:00 amRNSPrice Monitoring Extension
21st Mar 20239:05 amRNSSecond Price Monitoring Extn
21st Mar 20239:00 amRNSPrice Monitoring Extension
20th Mar 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.